title: Progression in keratoconus and the effect of corneal cross-linking on progression.
abstract: Ultraviolet corneal collagen cross-linking (CXL) has been shown to possibly delay, halt, or even reverse disease progression in keratoconus. Understanding of keratoconic progression in untreated eyes, however, is still incomplete and is hampered by the varying definitions and metrics used to evaluate corneal changes. As a result, the CXL literature varies widely in criteria for progression and parameters for successful outcomes. To date, there have been few long-term, well-controlled clinical trials supporting the efficacy of CXL to prevent progression in keratoconus. Review of our data on keratoconus suggests the course of corneal change is difficult to predict and that many keratoconic eyes appear stable once the eyes begin to exhibit frank changes in corneal curvature typical of keratoconus. Better-defined metrics for progression in keratoconus are needed. Larger, long-term randomized clinical trials may more clearly establish the efficacy and safety of CXL in the management of keratoconus and determine which patients are the best candidates for this procedure.
authors.affiliation: Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY.
authors.forename: Sarah E
authors.initials: SE
authors.lastname: Brown
authors.forename: Rubinee
authors.initials: R
authors.lastname: Simmasalam
authors.forename: Nataliya
authors.initials: N
authors.lastname: Antonova
authors.forename: Neha
authors.initials: N
authors.lastname: Gadaria
authors.forename: Penny A
authors.initials: PA
authors.lastname: Asbell
mesh_terms: D003094:Collagen / Q000378:metabolism; D003432:Cross-Linking Reagents / Q000627:therapeutic use*; D018450:Disease Progression; D006801:Humans; D007640:Keratoconus / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use; D012029:Refraction, Ocular / Q000502:physiology; D012307:Risk Factors; D014466:Ultraviolet Rays; D014792:Visual Acuity / Q000502:physiology
chemical_list: D003432:Cross-Linking Reagents; D017319:Photosensitizing Agents; D003094:Collagen